Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Lewisburg Livestock Market, Inc
WARNING LETTER
•Lewisburg Livestock Market, Inc•January 15, 2015

FDA WARNING_LETTER - Lewisburg Livestock Market, Inc - January 15, 2015

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

On January 7 and 15, 2015, the FDA inspected Lewisburg Livestock Market, Inc. in Lewisburg, Tennessee, and found violations of the Federal Food, Drug, and Cosmetic Act. A culled Black Angus cow sold on October 11, 2014, and slaughtered on October 15, 2014, contained florfenicol residues (19.36 ppm in liver, 6.99 ppm in muscle) exceeding the FDA tolerances (3.7 ppm in liver, 0.3 ppm in muscle). Additionally, flunixin residues (4.55 ppm in liver, 0.27 ppm in muscle) exceeded tolerances (0.125 ppm in liver, 0.025 ppm in muscle). This rendered the food adulterated under Section 402(a)(2)(C)(ii) of the Act.

The facility also held animals under insanitary conditions, leading to adulterated food under Section 402(a)(4). Specifically, the firm failed to maintain treatment records and lacked a system to ensure medicated animals were withheld from slaughter for appropriate withdrawal periods. Furthermore, the firm engaged in extralabel use of flunixin meglumine (Prevail®) by administering it without following the approved route and without the lawful order of a licensed veterinarian, violating 21 CFR 530.11(a

Company
Lewisburg Livestock Market, Inc
Inspection Date
January 15, 2015
Product Type
Drugs
Office
New Orleans District Office
People
  • Ruth P. Dixon (Program Division Director)
  • Scott E. Seebohm (Veterinary Medical Officer)
  • Jimmy Hopper
Open in Dashboard

ID · 01c891eb-4055-4325-a807-0d4e44615c48

Violation Codes10
21 U.S.C. 342(a)(2)(C)(i)21 U.S.C. 360b21 U.S.C. 342(a)(4)21 CFR 556.28321 CFR 556.28621 CFR 530.3(a)21 U.S.C. 360b(a)(4)21 U.S.C. 360b(a)(5)21 CFR 53021 CFR 530.11(a)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.